Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
MK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with MK-677?
Yes, CJC-1295 (without DAC) and MK-677 can generally be taken together. Different mechanisms; continuous ghrelin versus pulsatile GHRH.
Is CJC-1295 (without DAC) and MK-677 safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between CJC-1295 (without DAC) and MK-677?
Different mechanisms; continuous ghrelin versus pulsatile GHRH. This assessment has 90% confidence and is based on documented research data.
How should I time CJC-1295 (without DAC) and MK-677?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.